-+ 0.00%
-+ 0.00%
-+ 0.00%

*TG Therapeutics Raises 2026 Target BRIUMVI U.S. Net Product Revenue to About $890-$905 Million >TGTX

Dow Jones·08/03/2026 11:07:00

Please log in to view news